Patent classifications
C08K3/18
Coated particle
Provided is a urea compound-containing epoxy resin curing agent particle that can impart excellent storage stability and heat stability to an epoxy resin composition including a urea compound as a curing agent, while maintaining the solubility of the urea compound during heating and the fluidity after dissolution of the urea compound. The surface of the urea compound-containing epoxy resin curing agent particle is coated with a Group 4 or Group 13 element-containing alkoxide compound, chelate compound, and/or acylate compound.
CATALYST FOR EXTENDED WORK TIME FILLER COMPOSITION
A free radical cure catalyst composition is provided that includes a free radical cure catalyst present as a paste at 20° C. A cure inhibitor is dissolved in a solvent compatible with the free radical cure catalyst paste to form an inhibitor solution that is mixed into the paste. A filler composition is also provided that includes an ethylenically unsaturated resin, a crosslinking agent; and the free radical cure catalyst composition. A method of repairing a vehicle body is provided that includes an uncured layer of the composition as noted above is applied to a substrate. The uncured layer is modified during a working time of from 8 to 35 minutes. The uncured layer is allowed to cure under free radical conditions to form a cured layer.
ONE-PART ROOM-TEMPERATURE CURABLE COMPOSITIONS ON THE BASIS OF ORGANOSILICON COMPOUNDS AND TITANIUM CURING CATALYSTS
One-part room-temperature curable compositions (RTV-1 compositions) based on organosilicon compounds are less toxic compared to conventional compositions containing organotin compounds and, at the same time, have excellent curing properties, a skin formation time which allows proper handling and tooling, and excellent storage stability. The compositions contain: at least one organosilicon compound containing condensable groups; at least one curing agent having the formula R′Si(OOCR″).sub.3, wherein R′ is C.sub.3-C.sub.6 alkyl, and R″ is C.sub.1-C.sub.6 alkyl; at least one organotitanium compound curing catalyst; and at least one filler.
ONE-PART ROOM-TEMPERATURE CURABLE COMPOSITIONS ON THE BASIS OF ORGANOSILICON COMPOUNDS AND TITANIUM CURING CATALYSTS
One-part room-temperature curable compositions (RTV-1 compositions) based on organosilicon compounds are less toxic compared to conventional compositions containing organotin compounds and, at the same time, have excellent curing properties, a skin formation time which allows proper handling and tooling, and excellent storage stability. The compositions contain: at least one organosilicon compound containing condensable groups; at least one curing agent having the formula R′Si(OOCR″).sub.3, wherein R′ is C.sub.3-C.sub.6 alkyl, and R″ is C.sub.1-C.sub.6 alkyl; at least one organotitanium compound curing catalyst; and at least one filler.
ELECTROMAGNETIC WAVE ABSORBING THERMALLY CONDUCTIVE COMPOSITION AND SHEET THEREOF
An electromagnetic wave absorbing thermally conductive composition contains a matrix resin component, metal soft magnetic particles, and thermally conductive particles. The metal soft magnetic particles are carbonyl iron particles and are present in an amount of 30% by volume or more when the electromagnetic wave absorbing thermally conductive composition is a population parameter. A value of an imaginary part (μ″) of relative permeability of the electromagnetic wave absorbing thermally conductive composition is 0.9 or more in at least some bands in a frequency range of 18 to 26.5 GHz. The electromagnetic wave absorbing thermally conductive composition in the form of a sheet has a thermal conductivity of 2.0 W/m.Math.K or more in the thickness direction. A sheet of the present invention incudes the above composition in the form of a sheet. Thus, the present invention provides the electromagnetic wave absorbing thermally conductive composition and its sheet that can increase the value of the imaginary part (μ″) of relative permeability in a frequency band of 18 to 26.5 GHz, efficiently absorb electromagnetic wave noise in this frequency band, and also have a high thermal conductivity.
ELECTROMAGNETIC WAVE ABSORBING THERMALLY CONDUCTIVE COMPOSITION AND SHEET THEREOF
An electromagnetic wave absorbing thermally conductive composition contains a matrix resin component, metal soft magnetic particles, and thermally conductive particles. The metal soft magnetic particles are carbonyl iron particles and are present in an amount of 30% by volume or more when the electromagnetic wave absorbing thermally conductive composition is a population parameter. A value of an imaginary part (μ″) of relative permeability of the electromagnetic wave absorbing thermally conductive composition is 0.9 or more in at least some bands in a frequency range of 18 to 26.5 GHz. The electromagnetic wave absorbing thermally conductive composition in the form of a sheet has a thermal conductivity of 2.0 W/m.Math.K or more in the thickness direction. A sheet of the present invention incudes the above composition in the form of a sheet. Thus, the present invention provides the electromagnetic wave absorbing thermally conductive composition and its sheet that can increase the value of the imaginary part (μ″) of relative permeability in a frequency band of 18 to 26.5 GHz, efficiently absorb electromagnetic wave noise in this frequency band, and also have a high thermal conductivity.
MAGNETIC-INDUCED STIFFNESS CHANGED SOFT ROBOT DRIVE MODULE AND PRODUCTION METHOD THEREOF
A magnetic-induced stiffness changed soft robot drive module includes magnetic-induced stiffness changed layer, two-degree-of-freedom pneumatic driver, magnetic core and sealing fixing device. The magnetic-induced stiffness changed layer and two-degree-of-freedom pneumatic driver are printed and formed. The magnetic core can be deformed together with the driver, and a magnetic field can be generated when it is energized. After the magnetic core is installed into the two-degree-of-freedom pneumatic driver, then assembled with the sealing fixing device, a soft robot drive module with one end fixed is finished. The magnetic-induced stiffness changed layer has the fast, reversible and controllable stiffness adjustment ability under the action of electromagnetic field. As its hardness is greater than that of the two-degree-of-freedom pneumatic driver and its position is outside the air cavity, the two-degree-of-freedom pneumatic driver can be restricted from over-expansion and over-extension in the axial direction, making its pneumatic bending deformation controllable.
WINDOW, METHOD FOR MANUFACTURING WINDOW, AND ELECTRONIC DEVICE HAVING THE SAME
A window includes a coating layer including a front surface, a rear surface, a first region having a constant distance between the front surface and the rear surface in a thickness direction, and a second region in which a distance between the front surface and the rear surface reduces in a direction away from the first region; and a bezel layer disposed on the rear surface of the coating layer, where the coating layer includes inorganic particles, an acrylate resin and an epoxy resin.
WINDOW, METHOD FOR MANUFACTURING WINDOW, AND ELECTRONIC DEVICE HAVING THE SAME
A window includes a coating layer including a front surface, a rear surface, a first region having a constant distance between the front surface and the rear surface in a thickness direction, and a second region in which a distance between the front surface and the rear surface reduces in a direction away from the first region; and a bezel layer disposed on the rear surface of the coating layer, where the coating layer includes inorganic particles, an acrylate resin and an epoxy resin.
NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
The present invention encompasses compounds of formula (I)
##STR00001##
wherein the groups R.sup.1 to R.sup.7, A, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.